Natera is the lead sponsor of 12 current clinical trials in our USA register. 7 are recruiting patients now. The most common phase is Observational. The most-studied condition is Kidney Transplant Rejection.
| Study | Phase | Status | Start | Registers |
|---|---|---|---|---|
|
EXpanding Prenatal Cell Free DNA Screening Across moNogenic Disorders (EXPAND)
NCT06808880 · Single Gene NIPT
|
Observational | Recruiting | 2024-01 | USA |
|
Sample Collection for Ongoing Research and Product Evaluation Study - Non-Hodgkin Lymphoma (SCORE-NHL)
NCT07750886 · ClinicalTrials.gov ↗ · Non-Hodgkin Lymphoma, T-Cell Lymphoma, Diffuse Large B-Cell Lymphoma
|
Observational | Recruiting | 2026-07 | USA |
|
Sample Collection for Ongoing Research and Product Evaluation Study - Non-muscle Invasive Bladder Cancer (SCORE-NMIBC)
NCT07763197 · ClinicalTrials.gov ↗ · Non-Muscle Invasive Bladder Cancer, NMIBC, High-risk Non-Muscle Invasive Bladder Cancer
|
Observational | Recruiting | 2026-07 | USA |
|
Evaluation of the Natera Colorectal Cancer Screening Test in an Average Risk Population (FIND-CRC)
NCT07046585 · ClinicalTrials.gov ↗ · Colo-rectal Cancer
|
Observational | Recruiting | 2025-05 | USA |
|
Sample Collection for Ongoing Research and Product Evaluation Study
NCT07318051 · ClinicalTrials.gov ↗ · Breast Cancer, Lung Cancer, Muscle Invasive Bladder Cancer
|
Observational | Recruiting | 2025-07 | USA |
|
Prospective Collection of Samples to Enable the Development of Natera Screening Assay for Early Cancer Detection
NCT06620627 · ClinicalTrials.gov ↗ · Colorectal Cancer Screening
|
Observational | Recruiting | 2024-01 | USA |
|
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
NCT07214532 · ClinicalTrials.gov ↗ · Breast Neoplasms, Carcinoma, Ductal, Breast, Receptors, Estrogen (for ER-positive Requirement)
|
Not applicable | Recruiting | 2026-05 | USA |
|
Signatera Assessment in Early-Stage Endometrial Cancer
NCT07339384 · Endometrial Cancer
|
Not applicable | Not yet open | 2026-10 | USA |
|
The PROspera Kidney Transplant ACTIVE Rejection Assessment Registry (ProActive)
NCT04091984 · Kidney Transplant Rejection
|
Observational | Active, closed | 2019-11 | USA |
|
A Comparative Effectiveness Study in Heart Transplant Patients of Rejection Surveillance With Cell-free DNA Versus Endomyocardial Biopsy
NCT06414603 · Heart Transplant Failure and Rejection
|
Not applicable | Active, closed | 2024-06 | USA |
|
LAMBDA 002 (Lung Registry) Study
NCT05170425 · ClinicalTrials.gov ↗ · Lung Transplant Rejection
|
Observational | Active, closed | 2022-11 | USA |
|
Prospera Test Evaluation in Cardiac Transplant (ProTECT)
NCT05205551 · ClinicalTrials.gov ↗ · Heart Transplant Rejection
|
Observational | Active, closed | 2021-10 | USA |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in USA | 12 | 7 |
A trial with sites in more than one country appears in each of those registers.
| Sponsor | Trials |
|---|---|
| Sangamo Therapeutics | 1 |
Sponsors with the most current trials registered for this condition.
Natera is the lead sponsor of 12 current trials on ClinicalTrials.gov in our USA register, as of the registry sync on 26 September 2026. Completed and withdrawn studies are not counted.
Yes. 7 of its 12 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.
Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 26 Sep 2026.